Cargando…

Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis

Multiple myeloma (MM) is a common hematologic malignancy for which the underlying molecular mechanisms remain largely unclear. This study aimed to elucidate key candidate genes and pathways in MM by integrated bioinformatics analysis. Expression profiles GSE6477 and GSE47552 were obtained from the G...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Haimeng, Zheng, Gaofeng, Qu, Jianwei, Liu, Yang, Huang, Xi, Zhang, Enfan, Cai, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771956/
https://www.ncbi.nlm.nih.gov/pubmed/31215027
http://dx.doi.org/10.1002/jcp.28947
_version_ 1783455802246299648
author Yan, Haimeng
Zheng, Gaofeng
Qu, Jianwei
Liu, Yang
Huang, Xi
Zhang, Enfan
Cai, Zhen
author_facet Yan, Haimeng
Zheng, Gaofeng
Qu, Jianwei
Liu, Yang
Huang, Xi
Zhang, Enfan
Cai, Zhen
author_sort Yan, Haimeng
collection PubMed
description Multiple myeloma (MM) is a common hematologic malignancy for which the underlying molecular mechanisms remain largely unclear. This study aimed to elucidate key candidate genes and pathways in MM by integrated bioinformatics analysis. Expression profiles GSE6477 and GSE47552 were obtained from the Gene Expression Omnibus database, and differentially expressed genes (DEGs) with p < .05 and [logFC] > 1 were identified. Functional enrichment, protein–protein interaction network construction and survival analyses were then performed. First, 51 upregulated and 78 downregulated DEGs shared between the two GSE datasets were identified. Second, functional enrichment analysis showed that these DEGs are mainly involved in the B cell receptor signaling pathway, hematopoietic cell lineage, and NF‐kappa B pathway. Moreover, interrelation analysis of immune system processes showed enrichment of the downregulated DEGs mainly in B cell differentiation, positive regulation of monocyte chemotaxis and positive regulation of T cell proliferation. Finally, the correlation between DEG expression and survival in MM was evaluated using the PrognoScan database. In conclusion, we identified key candidate genes that affect the outcomes of patients with MM, and these genes might serve as potential therapeutic targets.
format Online
Article
Text
id pubmed-6771956
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67719562019-10-07 Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis Yan, Haimeng Zheng, Gaofeng Qu, Jianwei Liu, Yang Huang, Xi Zhang, Enfan Cai, Zhen J Cell Physiol Original Research Articles Multiple myeloma (MM) is a common hematologic malignancy for which the underlying molecular mechanisms remain largely unclear. This study aimed to elucidate key candidate genes and pathways in MM by integrated bioinformatics analysis. Expression profiles GSE6477 and GSE47552 were obtained from the Gene Expression Omnibus database, and differentially expressed genes (DEGs) with p < .05 and [logFC] > 1 were identified. Functional enrichment, protein–protein interaction network construction and survival analyses were then performed. First, 51 upregulated and 78 downregulated DEGs shared between the two GSE datasets were identified. Second, functional enrichment analysis showed that these DEGs are mainly involved in the B cell receptor signaling pathway, hematopoietic cell lineage, and NF‐kappa B pathway. Moreover, interrelation analysis of immune system processes showed enrichment of the downregulated DEGs mainly in B cell differentiation, positive regulation of monocyte chemotaxis and positive regulation of T cell proliferation. Finally, the correlation between DEG expression and survival in MM was evaluated using the PrognoScan database. In conclusion, we identified key candidate genes that affect the outcomes of patients with MM, and these genes might serve as potential therapeutic targets. John Wiley and Sons Inc. 2019-06-18 2019-12 /pmc/articles/PMC6771956/ /pubmed/31215027 http://dx.doi.org/10.1002/jcp.28947 Text en © 2019 The Authors. Journal of Cellular Physiology Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research Articles
Yan, Haimeng
Zheng, Gaofeng
Qu, Jianwei
Liu, Yang
Huang, Xi
Zhang, Enfan
Cai, Zhen
Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis
title Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis
title_full Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis
title_fullStr Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis
title_full_unstemmed Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis
title_short Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis
title_sort identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771956/
https://www.ncbi.nlm.nih.gov/pubmed/31215027
http://dx.doi.org/10.1002/jcp.28947
work_keys_str_mv AT yanhaimeng identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis
AT zhenggaofeng identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis
AT qujianwei identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis
AT liuyang identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis
AT huangxi identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis
AT zhangenfan identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis
AT caizhen identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis